HANNAH SAVELY: Open Payments
NPI 1265087464 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,330 in 208 payments from 22 companies in 2025. Trend: 2023 $2,916 · 2024 $3,447 · 2025 $4,330
Food & beverage: $3,845Education: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $590 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $512 |
| Janssen Biotech, Inc. | 15 | $497 |
| Novartis Pharmaceuticals Corporation | 28 | $455 |
| Galderma Laboratories, L.P. | 14 | $372 |
| UCB, Inc. | 10 | $236 |
| Regeneron Healthcare Solutions, Inc. | 14 | $234 |
| E.R. Squibb & Sons, L.L.C. | 12 | $199 |
| GENZYME CORPORATION | 9 | $199 |
| LEO Pharma Inc. | 12 | $179 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, COSENTYX, ILUMYA, SKYRIZI, Bimzelx.
Industry payments across MS — which companies pay providers there.
